These findings support the hypothesis that sustained treatment with mild Nrf2 inducers, such as 6-MSITC, may prevent the onset of cognitive impairment in a murine model of Alzheimer’s disease [38]. The gene discussed is NFE2L2; the disease is early-onset autosomal dominant Alzheimer disease.